SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Identified intangible assets (Details) - USD ($) $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2022 |
Dec. 31, 2021 |
|
| Indefinite-lived intangible assets | ||
| Impairment charge of intangible assets | $ 117,000 | |
| Amortization expense | 3,500 | $ 466 |
| Tradenames | ||
| Indefinite-lived intangible assets | ||
| Impairment charge of intangible assets | $ 117 | $ 0 |
| Doctor Agreements | ||
| Finite-lived intangible assets | ||
| Estimated useful life | 1 year | 10 years |
| Doctor Agreements | Intangible Assets, Amortization Period | ||
| Indefinite-lived intangible assets | ||
| Amortization expense | $ 3,100 | |
| Noncompete Agreements | ||
| Finite-lived intangible assets | ||
| Estimated useful life | 2 years | |
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|